Cutaneous adverse drug reactions to targeted chemotherapeutic drugs: A clinico-epidemiological study
Conclusion: There has been a paradigm shift in the management of both hematopoietic and solid cancers with the advent of targeted chemotherapeutic drugs leading to an increase in uncommon and specific drug reactions. Early recognition of these decreases morbidity, improves quality of life, and allows continuation of the life saving chemotherapy.
Source: Indian Journal of Dermatology - Category: Dermatology Authors: Kriteeka Saini Amita Sutaria Bela Shah Vinita Brahmbhatt Kirti Parmar Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Dermatitis | Dermatology | Drugs & Pharmacology | Epidemiology | India Health | Skin | Study